ATE427119T1 - Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung - Google Patents
Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendungInfo
- Publication number
- ATE427119T1 ATE427119T1 AT02801021T AT02801021T ATE427119T1 AT E427119 T1 ATE427119 T1 AT E427119T1 AT 02801021 T AT02801021 T AT 02801021T AT 02801021 T AT02801021 T AT 02801021T AT E427119 T1 ATE427119 T1 AT E427119T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- rabies vaccine
- recombinant rabies
- rabies virus
- recombinant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32835001P | 2001-10-10 | 2001-10-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE427119T1 true ATE427119T1 (de) | 2009-04-15 |
Family
ID=23280622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02801021T ATE427119T1 (de) | 2001-10-10 | 2002-10-10 | Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung |
Country Status (6)
Country | Link |
---|---|
US (1) | US7223584B2 (de) |
EP (1) | EP1439856B1 (de) |
AT (1) | ATE427119T1 (de) |
CA (1) | CA2463090C (de) |
DE (1) | DE60231821D1 (de) |
WO (1) | WO2003030933A1 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003087339A2 (en) * | 2002-04-11 | 2003-10-23 | Medimmune Vaccines, Inc. | Spray freeze dry of compositions for pulmonary administration |
EP1768697B1 (de) | 2004-07-12 | 2010-06-02 | Thomas Jefferson University | Zusammensetzungen mit rekombinantem tollwutvirus |
US7863041B2 (en) | 2005-10-14 | 2011-01-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Rabies virus vector systems and compositions and methods thereof |
BRPI0919174B1 (pt) * | 2008-09-17 | 2020-11-17 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | vírus da raiva recombinante, composição imunogênica e seu uso |
US8282939B2 (en) * | 2009-09-11 | 2012-10-09 | Thomas Jefferson University | Attenuated live triple G protein recombinant rabies virus vaccine for pre- and post-exposure prophylaxis of rabies |
CN101768575B (zh) * | 2010-01-15 | 2013-06-12 | 中国农业科学院哈尔滨兽医研究所 | 双表达g基因的重组狂犬病病毒的构建及其生物学特性分析 |
EP2585598B1 (de) | 2010-06-24 | 2015-12-30 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services | Pan-lyssavirus-impfstoffe gegen tollwut |
CN103323588A (zh) * | 2012-03-19 | 2013-09-25 | 郑州中道生物技术有限公司 | 一种犬狂犬病毒抗体的检测方法及检测试剂盒 |
WO2014055289A1 (en) * | 2012-10-01 | 2014-04-10 | Thomas Jefferson University | Immunization with rabies virus vector expressing foreign protein antigen |
CN104599668B (zh) * | 2014-12-18 | 2018-02-02 | 清华大学 | 基于稀疏矩阵快速语音识别方法和装置 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2693655B1 (fr) | 1992-07-20 | 1994-10-14 | Virbac | Vaccin antirabique avirulent. |
US6295531B1 (en) * | 1998-11-09 | 2001-09-25 | Unisys Corporation | Cool ICE data wizard |
US7074413B2 (en) | 2000-03-23 | 2006-07-11 | Thomas Jefferson University | Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife |
US6708173B1 (en) * | 2000-10-18 | 2004-03-16 | Unisys Corporation | Method and apparatus for multiple application trace streams |
US6836886B2 (en) * | 2001-03-19 | 2004-12-28 | Autodesk, Inc. | Method and apparatus for delivering electronic information |
-
2002
- 2002-10-10 DE DE60231821T patent/DE60231821D1/de not_active Expired - Lifetime
- 2002-10-10 EP EP02801021A patent/EP1439856B1/de not_active Expired - Lifetime
- 2002-10-10 US US10/268,197 patent/US7223584B2/en not_active Expired - Lifetime
- 2002-10-10 AT AT02801021T patent/ATE427119T1/de not_active IP Right Cessation
- 2002-10-10 WO PCT/US2002/032475 patent/WO2003030933A1/en not_active Application Discontinuation
- 2002-10-10 CA CA2463090A patent/CA2463090C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2463090C (en) | 2012-06-12 |
US20030113346A1 (en) | 2003-06-19 |
WO2003030933A1 (en) | 2003-04-17 |
EP1439856A4 (de) | 2005-01-19 |
CA2463090A1 (en) | 2003-04-17 |
EP1439856B1 (de) | 2009-04-01 |
DE60231821D1 (de) | 2009-05-14 |
US7223584B2 (en) | 2007-05-29 |
EP1439856A1 (de) | 2004-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE527281T1 (de) | Impfstoffe gegen aids umfassend cmv/r nucleinsäurekonstrukte | |
DE60139026D1 (de) | Lebender influenza impfstoff und verfahren zu seiner herstellung | |
CY1106785T1 (el) | Ιικα σωματιδια τα οποια απελευθερωνονται μετα απο μολυνση απο ανθρωπινο κυτταρομεγαλοϊο και η χρηση τους ως εμβολιο | |
WO2001091536A3 (en) | Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens | |
EP1504112A4 (de) | Entwicklung einer vakzine zur prävention von infektionen mit dem filovirus bei primaten | |
WO2005062820A3 (en) | Multi plasmid system for the production of influenza virus | |
NO20001768D0 (no) | Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav | |
NO20056074L (no) | Hoy titer rekombinante influensavira til vaksiner og genterapi | |
ATE526411T1 (de) | Avirulente, immunogene flavivirus-chimäre | |
WO2007024941A3 (en) | Polyvalent vaccine | |
FR2827605B1 (fr) | Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin | |
ATE427119T1 (de) | Rekombinante tollwut-vakzine und verfahren zu ihrer herstellung und verwendung | |
WO2002087494A3 (en) | Novel vaccine | |
WO2003066094A3 (en) | Hepatitis b vaccines | |
MY128999A (en) | Purification of hbv antigens for use in vaccines | |
ATE526034T1 (de) | Verbesserte inaktivierte fcv-vakzinen | |
DE60222296D1 (de) | Impfstoff von umhüllten viren und verfahren zu seiner herstellung | |
CY1107560T1 (el) | Ζωντανα εξασθενημενα βακτηρια για χρηση σε εμβολιο | |
DK1272652T3 (da) | Herpesvirus til immunmodulation | |
NO20020615L (no) | Vaksine | |
DE60040219D1 (de) | Infektiöses cdna klon des gb-virus b und dessen verwendungen | |
TW200509964A (en) | VP1 of foot-and-mouth disease virus | |
ATE283066T1 (de) | Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp) | |
ATE505482T1 (de) | Impfstoff gegen infektiöses lachsanämievirus | |
WO2006078272A3 (en) | Rhabdoviral n-fusion proteins as carrier for foreign antigens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |